Mylan releases Clozapine Orally Disintegrating Tablets in U.S.

November 24, 2015

Mylan N.V. today announced the U.S. launch of Clozapine Orally Disintegrating Tablets, 25 mg and 100 mg, the generic version of Jazz Pharmaceutical's FazaClo.

Previous Article
Catasys to provide assistance to Humana members experiencing substance abuse challenges
Catasys to provide assistance to Humana members experiencing substance abuse challenges

Catasys, Inc., a provider of proprietary big-data based analytics and predictive modeling driven health man...

Next Article
Sound Physicians agrees to provide hospitalist services for Mount Vernon's Skagit Valley Hospital
Sound Physicians agrees to provide hospitalist services for Mount Vernon's Skagit Valley Hospital

Sound Physicians, a health care organization focused on improving quality and lowering cost throughout the ...